Orasis’ presbyopia eyedrop meets primary endpoint in phase 2b trial
- Posted on: Oct 22 2019
- Leave a response
A corrective eyedrop for presbyopia is progressing through the regulatory pipeline as encouraging findings emerge from a phase 2b study.
Source: AAO
Posted in: Uncategorized
